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Abstract
Background: Staphylococcal toxicity and antibiotic resistance (STAAR) have been menacing public health. Although
vancomycin-resistant Staphylococcus aureus (VRSA) is currently not as widespread as methicillin-resistant S. aureus
(MRSA), genome evolution of MRSA into VRSA, including strains engineered within the same patient under
anti-staphylococcal therapy, may build up to future public health concern. To further complicate diagnosis, infection
control and anti-microbial chemotherapy, non-sterile sites such as the nares and the skin could contain both S. aureus
and coagulase-negative staphylococci (CoNS), either of which could harbour mecA the gene driving staphylococcal
methicillin-resistance and required for MRSA-VRSA evolution.
Results: A new heptaplex PCR assay has been developed which simultaneously detects seven markers for: i) eubacteria
(16S rRNA), ii) Staphylococcus genus (tuf), iii) Staphylococcus aureus (spa), iv) CoNS (cns), v) Panton-Valentine leukocidin
(pvl), vi) methicillin resistance (mecA), and vii) vancomycin resistance (vanA). Following successful validation using 255
reference bacterial strains, applicability to analyse clinical samples was evaluated by direct amplification in spiked blood
cultures (n = 89) which returned 100 % specificity, negative and positive predictive values. The new assay has LoD of
1.0x103 CFU/mL for the 16S rRNA marker and 1.0x104 CFU/mL for six other markers and completes cycling in less than
one hour.
Conclusion: The speed, sensitivity (100 %), NPV (100 %) and PPV (100 %) suggest the new heptaplex PCR assay could
be easily integrated into a routine diagnostic microbiology workflow. Detection of the cns marker allows for unique
identification of CoNS in mono-microbial and in poly-microbial samples containing mixtures of CoNS and S. aureus
without recourse to the conventional elimination approach which is ambiguous. In addition to the SA-CoNS differential
diagnostic essence of the new assay, inclusion of vanA primers will allow microbiology laboratories to stay ahead of
the emerging MRSA-VRSA evolution. To the best of our knowledge, the new heptaplex PCR assay is the most
multiplexed among similar PCR-based assays for simultaneous detection of STAAR.
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Background
Accumulation of genes encoding staphylococcal toxigen-
icity and antibiotic-resistance (STAAR) in the genus
Staphylococcus is well documented. The evolution of
STAAR factors in Staphylococcus aureus has resulted to
the emergence of strains associated with infections
recently described as life-threatening and refractory to
therapy [1, 2]. Some bacterial factors are not easily
detected by conventional agar-based bacteriological cul-
tures. PCR-based assays are capable of identifying the
genetic capacity for STAAR without the influence of
variability in gene expression [3] and are preferred for
speed and sensitivity.
Genome evolution is responsible for the emergence of
strains harbouring STAAR factors some of which pose
diagnostic challenges. For detection of mecA-encoded
staphylococcal methicillin resistance, several investiga-
tors have reported multiplex PCR assays which accur-
ately detected mecA gene and correlated well with the
oxacillin phenotype [4, 5]. Since S. aureus and coagulase-
negative staphylococci (CoNS) harbor the mecA gene in
common, Huletsky and colleagues highlighted the need
for a discriminatory assay capable of identifying the co-
habitation of S. aureus and coagulase-negative staphylo-
cocci (CoNS) especially in non-sterile sites such as the
nares and the skin [6]. They discriminated S. aureus from
CoNS by detecting DNA from the staphylococcal cassette
chromosome (SCC) using oligonucleotides which hybri-
dised to the S. aureus open reading frame encoding
unknown function (orfX) [6]. However, commercial assays
inspired by the orfX oligos attracted numerous reports of
assay failure because some SCC types which lacked the
mecA gene were misidentified as MRSA [7, 8].
Basically, there are PCR-based assays for species identifi-
cation of CoNS [9–11]. However, as the taxa of clinically
relevant member species of the genus Staphylococcus
continues expanding [12, 13], no species-specific assay
has been capable of detecting all the species in one
PCR tube. Consequently, PCR-based assays for identifi-
cation of CoNS have relied on elimination based on the
absence or non-detection of S. aureus markers such as
coa, nuc, spa or femA [14]. Although the elimination
approach may yield good results for mono-microbial
infections, lack of a unique marker for CoNS renders
such assays unreliable for identification of CoNS in
poly-microbial samples containing both S. aureus and
CoNS.
Recently the genomes of some MRSA strains evolved
further. As a result of the acquisition of the vanA gene
from enterococci vancomycin-resistant S. aureus (VRSA)
evolved among MRSA strains [15, 16]. The recent emer-
gence of VRSA in Portugal [17] may lead to the spread
of VRSA in Europe and beyond. Furthermore, the in-
crease in the incidence of MRSA strains belonging to
the CC5 clade associated with hospital MRSA-VRSA
evolution in different parts of the globe [18], including
the case of the Brazilian patient whose own bloodstream
vancomycin-susceptible MRSA (VS-MRSA) acquired
vanA during antibiotic therapy and became VRSA [19]
and the 13.3 % incidence of VRSA in some hospitals
[20], collectively point to the hazardous capacity of this
lineage, suggesting that the genetic engineering and dis-
semination of community associated MRSA containing
vanA could escalate to a serious public health concern.
The recent report of 46.2 % VRSA among MRSA strains
isolated in chickens [21] further suggests that VRSA
constitutes an impending threat to public health.
In line with the identified need for multiplex PCR
assays capable of detection of multiple microbes or mul-
tiple genetic markers within the same PCR tube [22], we
aimed to develop a multiplex PCR assay. Our experi-
ments resulted in a new heptaplex PCR assay which
simultaneously detected seven DNA markers for: (i) 16S
rRNA (ubiquitous bacteria), (ii) spa (S. aureus), (iii) tuf
(the genus Staphylococcus spp.), (iv) cns (CoNS), (v) pvl
(PVL virulence factor), (vi) mecA (methicillin resistance),
and (vii) vanA (vancomycin resistance).
Methods
Bioethics and biosafety
The Research Committee, University of Nottingham,
approved this study. Human-associated materials, in-
cluding clinical bacterial isolates and blood cultures,
were de-identified so they could not be tracked back to
the patients. Many of the bacterial strains used in this
study were obtained from the Network for Antibiotic
Resistance in Staphylococcus aureus (NARSA) Strain Re-
pository (www.narsa.net), some of which are putatively
multi-resistant and/or highly virulent. An enhanced level
2 (BSL2+) suite was provided for storage and work on
such potentially hazardous agents. Local strains were
manipulated completely in the general (BSL2) laboratory
space.
Bacterial strains and bacteriological media used for this
study
All bacteriological media and consumables used for this
study were purchased from Oxoid, Basingstoke, UK.
Bacterial strains (n = 255) were sub-cultured from stor-
age (−80 °C) into brain heart infusion (BHI) broth and
plated out on BHI agar. From BHI plates, a 0.5 McFar-
land standardised inoculum was generated for each
isolate and used for gene detection and phenotypic tests.
Reference type cultures (n = 53) comprising staphylococ-
cal strains were used to validate the 7 genetic markers
targeted by the new heptaplex PCR assay. Identification
of the sources of the type cultures along with the num-
bers of strains belonging to S. aureus and CoNS are
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indicated (Additional file 1). Local clinical staphylococcal
strains (n = 124) were collected from the hospitals in the
Nottingham area (August 2003 - December 2004). They
were previously characterized by the Queen’s Medical
Centre (QMC) Nottingham NHS microbiology labora-
tory and de-identified by Dr. Richard Spence who used
them for DNA microarrays [23]. CoNS strains (n = 31)
donated by Nottingham University’s Centre for Biomo-
lecular Sciences (CBS) researchers who previously
characterized them as S. auricularis (2), S capitis (2), S.
caprae (2), S. chromogenes (2), S. cohnii (2), S. epidermi-
dis (2), S. hemolyticus (1), S. hominis (2), S. hyicus (2), S.
intermedius (2), S. lugdunensis (1), S. saprophyticus (3),
S. sciuri (2), S. simulans (2), S. warneri (2) and S. xylosus
(2) were included. Other (non-staphylococcal) bacteria
(n = 47) previously characterized and de-identified by
CBS researchers including strains of Escherichia coli,
Pseudomonas spp., Klebsiella spp., Aeromonas spp.,
Salmonella spp., Citrobacter spp., Proteus spp., and
Group A streptococci (GAS) were also used.
Preparation of bacterial DNA
Preparation of bacterial cell lysates from NARSA strains
followed a heating and centrifugation method reported
elsewhere [24]. Bacterial DNA was obtained from spiked
blood culture by Triton X-100 cell lysis method [25].
Following bacterial cell lysis step, the DNA-rich super-
natant was transferred into a fresh 0.5 mL Eppendorf
tube for PCR in the general (BSL2) laboratory. The lysis
step was waived for local strains: bacterial colonies were
directly picked and used in PCR. Similarly, broths were
applied directly into PCR as previously evaluated in our
laboratory and found reliable [24].
Development and optimization of the heptaplex PCR
The spa, pvl and mecA primers were originally published
by Nakagawa et al. [26]; they reliably detected spa, pvl
and mecA in our laboratory [24]. The cns and 16S rRNA
primers were copied from a recently published pentaplex
real-time PCR assay [27]. Following other reports [28,
29], multiple alignments in clustalW (www.ebi.ac.uk/
tools/clustalW) were used to design the primers target-
ing tuf and vanA. The greater discriminatory power of
staphylococcal tuf over 16S rRNA for identification of
CoNS has been reported [30] and was exploited in this
assay. To supply all the seven key genetic loci targeted
in the new PCR, a mixed infection model comprising 3
staphylococcal strains was made up. The strains used to
generate the mixed infection model were: i) vancomycin-
resistant S. aureus strain VRS1 (16S, tuf, spa, vanA and
mecA), ii) PVL-positive MSSA strain NRS157 (16S, tuf,
spa, and pvl), and iii) methicillin susceptible CoNS strain
S. lugdunensis NCTC12217 (16S, tuf, and cns). Bacterial
cell lysates (10 μL), broth cultures or direct bacterial
colonies were used as template for PCR in a 40 μL vol-
ume. Beginning with the five primer sets recently reported
in our laboratory [27] and in a stepwise manner, the num-
ber of markers detected was scaled up to seven by adding
two new primer sets targeting tuf and vanA genes. Follow-
ing recent reports [31, 32], Candida albicans (n = 4) were
used as non-bacterial negative control template while the
16S rRNA marker for ubiquitous bacteria served as a
positive control in every PCR reaction containing bacterial
DNA. The PCR was performed using Eppendorf master-
cycler (Eppendorf, Hamburg, Germany). The cycling con-
ditions were copied from a recent pentaplex real-time
PCR assay [27]. Briefly, an initial single cycle for 5 minutes
at 94 °C was followed by 40 cycles consisting of 15 seconds
at 94 °C (denaturation) and 5 seconds at 60 °C (amplifica-
tion) with one final run of 30 seconds at 72 °C (final poly-
merase extension). PCR optimization followed recent
strategies [33, 34]: hot-start PCR was performed in which
Taq DNA polymerase was withheld until the cycler
showed the reaction temperature was above 85 °C. The
PCR mixture contained 0.500 mM of dNTPs, 10U of Taq
DNA polymerase (New England Biolabs, UK) and thermo-
pol buffer (pH 8.8 at 25 °C, 5 μL) comprising: 20 mM
Tris–HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4,
0.1 % Triton X-100. Bacterial cell lysates (10 μL) from
spiked blood cultures were used as template for PCR in a
40 μL volume. PCR amplicons were resolved by electro-
phoresis (200 V, 3 hours) in 4 % agarose gel containing
Ethidium bromide (0.5 g/L) and visualised in UV trans-
illuminator (UVP, UK). PCR products were purified
from agarose gels using GenElute™ (Sigma, UK). Sequencing
reactions were prepared by BigDye™ protocol (AppliedBio-
systems, USA) and analysed using ABI Prism 310 Genetic
analyser (AppliedBiosystems, USA). Identity of PCR
amplicons was confirmed by BLAST search on NCBI da-
tabases (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The limit
of detection (LoD) was determined by ten-fold serial dilu-
tions performed on a 0.5 McFarland inoculum. Following
isolation on BHI plates, Gram staining was performed to
differentiate Gram-positive from Gram-negative bacteria.
Tube coagulase test (TCT) was used to differentiate S.
aureus from CoNS. Oxacillin salt agar screen (OSAS)
containing 4 % NaCl, reported elsewhere as most reliable
especially for CoNS [35, 36] was performed according to
the agar dilution methods recommended by the CLSI
[37]. For identification of staphylococcal vancomycin
phenotype, vancomycin agar screen (VAS) was performed
and interpreted according to CLSI [38]. Following CLSI
recommendations [38, 39], Mueller-Hinton agar was
used in disk diffusion method to screen for: (i)
oxacillin-resistance using 1.0 μg oxacillin disc; and (ii)
vancomycin-resistance using 6.0 μg vancomycin disc.
For assay reproducibility, positive and negative charac-
ters were inferred upon the agreement of results
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obtained from four or more repeated gene detection
and phenotypic tests performed on different days: the
same 0.5McFarland inoculum prepared for PCR was
used for phenotypic tests including colony counts.
Aside from gene amplification from the bacterial strains
performed directly on the frozen material, directly from
BHI broth and directly from discrete colonies grown on
BHI agar, the capacity of the new assay to detect the
seven genetic markers directly from clinical samples
was studied using spiked blood cultures containing bac-
terial strains in mono-microbial and poly-microbial
models. Spiking of blood cultures followed a recent re-
port for direct identification of staphylococci from
blood culture material [40] with modifications. Briefly,
the de-identified clinical blood culture bottles which
have been cultured for 1 week and remained negative,
derived from routine diagnostic microbiology, were
spiked and then tested by PCR. Detected sequences
were analysed as negative predictive values (NPV) and
positive predictive values (PPV) according to recent
CLSI guidelines [41].
Results and discussion
Multiple alignments in clustalW enabled the identifica-
tion of loci within the nucleotide sequences of target
genes for suitable primer hybridization. Although the de-
tection of tuf gene as a marker for the identification of
the genus Staphylococcus is well documented [42], the
new heptaplex PCR is the first end-point PCR-based
assay which demonstrated the discriminatory power of
some polymorphic regions of the staphylococcal tuf for
unique detection of CoNS. This allows the simultaneous
detection of markers specific for S. aureus and CoNS
within the same PCR tube without recourse to the con-
ventional elimination approach thus allowing mixtures
of S. aureus and CoNS to be identified without cumber
and ambiguity.
Bioinformatic analysis initially identified AAGACTG
CACGTTCAGGCTC, a 20-letter oligonucleotide se-
quence as the vanA forward primer. Though the former
vanA forward primer generated a vanA positive ampli-
con with very high specificity in a 235 bp monoplex
PCR [29], it interfered with other reactions. Replacement
of the interfering primer with the current vanA forward
primer listed in Table 1 generated a 111 bp amplicon
without interference thus allowing the simultaneous
amplification of all the seven markers targeted by the
new heptaplex PCR (Fig. 1).
The 111bp vanA marker was amplified from all (100%)
VRSA reference strains listed in Additional file 1. Upon
these findings, it was inferred that useful as in silico bio-
informatics work-up is in PCR primer prediction, wet
experimentation is still needed to confirm the reliability
of PCRs developed from such predictions. This is par-
ticularly important as very powerful bioinformatics tools
are entering the oligo-design research arena, including
those capable of aligning nearly a million sequences of
the bacterial 16S rRNA gene [31]. Also, the lack of amp-
lification in the negative control PCRs containing C.
albicans template (Fig. 1 lane 2 and Fig. 2 lanes 5 and
11) further attests to the specificity of the new assay
which is illustrated using numerous reference strains
and their combinations (Fig. 2).
The optimal concentration of the oligonucleotide
primers which yielded clearly detectable amplification
products in the new heptaplex PCR assay were found to
be 0.50 μM for cns and 0.75 μM for the other six targets.
Gene detection in spiked blood cultures, including
mono- and poly-microbial cultures, showed the new
assay detected all the seven targets (Additional file 2).
Additional file 2 also shows that all the expected genes
were correctly detected with 100 % specificity, NPV, and
PPV thus enabling assignment of MSSA, PPMSSA,
MRSA, PPMRSA, MSCoNS, MRCoNS, and VRSA. No
PCR product was generated from the eukaryotic
template, C. albicans, used as PCR negative control, a
finding which supports its use as negative control for
bacterial PCRs [31, 32].
The 111 bp vanA marker was not detected in the local
clinical isolates. Thus the new assay corroborates the
Fig. 1 Development of the new heptaplex PCR showing the amplification of single and multiple DNA markers. Lane 1: 100 bp DNA Marker
(New England Biolabs, NEB, UK) with upper band [200 bp] and lower band [100 bp], Lane 2: PCR negative control [Candida albicans], Lane 3:
coagulase-negative staphylococcus marker [cns, 204 bp], Lane 4: bacterial 16S rRNA marker [16S, 174 bp], Lane 5: mecA marker [mecA, 155 bp],
Lane 6: staphylococcus genus translation elongation factor marker [tuf, 143 bp], Lane 7: Panton-Valentine leukocidin marker [pvl, 118 bp], Lane 8:
Vancomycin resistance marker [vanA, 111 bp], Lane 9: staphylococcal protein A marker [spa, 101 bp], Lane 10: Heptaplex PCR showing all seven markers
(cns, 16S, mecA, tuf, pvl, vanA and spa) from top to bottom respectively
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QMC phenotypic data for the local clinical staphylococci
in agreement with the fact that they were uniformly sus-
ceptible to vancomycin by the VAS used to support
vanA PCR in this study. However, one of the local
strains showed discrepancy between the QMC data and
gene detection by the new assay. Previously identified
as methicillin susceptible Staphylococcus epidermidis
(MSSE), the strain in question yielded PCR products
for 16S, tuf, mecA and cns which together characterize
MRCoNS (typical of Fig. 2 lane 2). The oxacillin 1 μg
disk diffusion method identified the strain as MSCoNS.
Interestingly, there was growth on the 0.5 mg/L
Fig. 2 Validation of the new heptaplex PCR assay. Lanes 1 and 8: 100 bp DNA ladder (NEB, UK); Lane 2: MRCoNS strain S. epidermidis NRS8
showing the markers cns, 16S, mecA, and tuf; Lane 3: Nottingham local MSCoNS showing the markers cns, 16S, and tuf; Lane 4: Group A
Streptococcus showing only the 16S marker for bacterial 16SrRNA gene; Lanes 5 and 11: PCR negative control (Candida albicans); Lane 6: VRSA
strain VRS1 showing the markers 16S, mecA, tuf, vanA, and spa; Lanes 7 and 14: mixed template comprising vancomycin-resistant S. aureus strain
VRS1, methicillin susceptible CoNS strain S. lugdunensis NCTC12217 and PVL-positive MSSA strain NRS157 and showing all the seven markers (cns,
16S, mecA, tuf, pvl, vanA, and spa); Lane 9: PVL-negative MRSA strain Sanger252 showing the markers 16S, mecA, tuf, and spa; Lane 10: PVL-negative
MSSA strain Sanger476 showing the markers 16S, tuf, and spa; Lane 12: PVL-positive MSSA strain NRS157 showing the markers 16S, tuf, pvl, and spa;
Lane13: PVL-positive S. aureus strain USA400 (MW2) showing the markers 16S, mecA, tuf, pvl, and spa
Table 1 Oligonucleotide primers used in the heptaplex PCR assay
Target DNA Amplicon size (bp) Primer Identity Primer sequence 5’→ 3’ Reference
cns 204 cns-1 TATCCACGAAACTTCTAAAACAACTGTTACT [27]
cns-2 TCTTTAGATAATACGTATACTTCAGCTTTGAATTT
16S rRNA 174 16S-1 CTAGTAATCGCGGATCAGCAT [27]
16S-2 GATACGGCTACCTTGTTACGACTT
mecA 155 mecA-1 TGGTATGTGGAAGTTAGATTGGGAT [26]
mecA-2 CTAATCTCATATGTGTTCCTGTATTGGC
tuf 143 tuf-1 TACCAGCATTAGTAGTATTCTTAAACAAAGTTG This study
tuf-2 TGCTGAACCAGCGATTACAG
pvl 118 pvl-1 TTACACAGTTAAATATGAAGTGAACTGGA [26]
pvl-2 AGCAAAAGCAATGCAATTGATG
vanA 111 vanA-1 GCTGTGAGGTCGGTTGTG This study
vanA-2 GCTCGACTTCCTGATGAATACG
spa 101 spa-1 CAGCAAACCATGCAGATGCTA [26]
spa-2 CGCTAATGATAATCCACCAAATACA
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oxacillin plate while increasing concentrations inhibited
the strain.
For taxonomical purposes, the relevance of species-
specific PCR-based assays cannot be undermined
though. However, owing to the continuing expansion in
the taxa of clinically relevant member species of the
genus Staphylococcus [12, 13], there is yet no species-
specific PCR-based assay capable of identifying all clinic-
ally relevant CoNS in one PCR tube. This puts a limita-
tion on species-specific PCR-based assays. To
circumvent this, the new heptaplex PCR assay identifies
all CoNS by detection of the cns marker. Similarly, the
detection of the 16S rRNA in all (100 %) bacteria studied
including staphylococcal and non-staphylococcal strains
supports the use of this gene as a diagnostic marker for
bacteria [43]. Though the use of higher oxacillin concen-
trations recommended by the CLSI [38, 39] have been
reported elsewhere [44], the 0.5 mg/L oxacillin used in
this study supports the recent report of low oxacillin-
resistant staphylococci (MIC = 0.5 mg/L) in the UK [45].
In view of the variations in gene expression, it has been
suggested that mecA-positive staphylococci showing
low-level oxacillin-resistance should be regarded as con-
stitutively oxacillin-resistant [3].
The new assay completes cycling within an hour which
compares favourably with a recent PVL/MRSA real-time
PCR assay [45]. The total turn-around-time was less
than 4 hours which also compares favourably with re-
cent end-point PCR assays [41], while the LoD was
found to be 1.0x103 CFU/mL (for 16S rRNA marker)
and 1.0x104 CFU/mL (for the other six markers). These
parameters further support the usefulness of the new
heptaplex PCR assay in routine clinical diagnosis and in-
fection control.
Conclusion
Though the absence of vanA in Nottingham local clin-
ical strains corroborates the vancomycin phenotype, the
recent finding of VRSA in Portugal and the report of
46.2 % VRSA in chickens are pointers that the new hep-
taplex PCR assay will find relevance in routine diagnosis
and infection control. Also, the detection of the cns se-
quence which is unique to CoNS and completely inde-
pendent of S. aureus gene (spa) shows that the new
assay will allow microbiology laboratories to easily iden-
tify the presence of both CoNS and S. aureus directly in
poly-microbial specimens.
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